Chemours (CC) Non-Current Deferred Tax Liability (2014 - 2026)

Chemours' Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $40.0 million for Q1 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 42.86% year-over-year to $40.0 million in Q1 2026; TTM through Mar 2026 was $40.0 million, a 42.86% increase from a year earlier, with the FY2025 full-year figure at $37.0 million, up 5.71% from the prior year.
• Non-Current Deferred Tax Liability grew to $40.0 million in Q1 2026 per CC's latest filing, from $37.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $61.0 million in Q4 2022 and bottomed at $27.0 million in Q3 2025.
• The 5-year median for Non-Current Deferred Tax Liability is $44.0 million (2023), against an average of $44.4 million.
• Across the five-year window, Non-Current Deferred Tax Liability plunged 36.36% in 2025 and soared 42.86% in 2026, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $61.0 million in 2022, then dropped by 27.87% to $44.0 million in 2023, then retreated by 20.45% to $35.0 million in 2024, then rose by 5.71% to $37.0 million in 2025, then grew by 8.11% to $40.0 million in 2026.
• Per Business Quant, the three latest CC Non-Current Deferred Tax Liability figures stand at $40.0 million (Q1 2026), $37.0 million (Q4 2025), and $27.0 million (Q3 2025).